10-F672281 - 3-cyclopentyloxypropanenitrile
Sorry, no product with reference 10-F672281 been found, but please check out the following similar products:
3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
CAS:Formula:C11H14BrN3Purity:95%Molecular weight:268.1530(R)-3-(4-Bromo-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile
CAS:(R)-3-(4-Bromo-1H-Pyrazol-1-Yl)-3-CyclopentylpropanenitrilePurity:99%Molecular weight:268.15g/mol(R)-3-(4-(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
CAS:(R)-3-(4-(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrilePurity:95%Molecular weight:340.82g/mol(S)-3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
CAS:(S)-3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrilePurity:98%Molecular weight:268.16g/mol(R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate
CAS:(R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphatePurity:98%Molecular weight:404.36g/mol3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
CAS:3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrilePurity:95%Molecular weight:268.15g/mol(R)-3-(4-(6-Amino-5-formylpyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
CAS:Controlled ProductFormula:C16H18N6OColor and Shape:NeatMolecular weight:310.3541H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βS)-
CAS:Formula:C17H18N6Purity:98%Color and Shape:SolidMolecular weight:306.36503-Cyclopentyl-3-oxopropanenitrile
CAS:Formula:C8H11NOPurity:98%Color and Shape:LiquidMolecular weight:137.1790Ruxolitinib Phosphate
CAS:Formula:C17H18N6·H3O4PColor and Shape:White To Off-White SolidMolecular weight:306.37 97.99Ruxolitinib Impurity 2 p-Toluenesulfonate
CAS:Formula:C16H18N6O·C7H8O3SColor and Shape:Off-White SolidMolecular weight:310.36 172.20(S)-Ruxolitinib Phosphate
CAS:Controlled ProductApplications The phosphate salt of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.
References Shilling, A.D. et al.: Drug Metab. Disp., 38, 2023 (2010); Mesa, R.A.: IDrugs, 13, 394 (2010); Campas-Moya, C.: Drugs Fut., 35, 457 (2010);Formula:C17H18N6•H3PO4Color and Shape:White To Off-WhiteMolecular weight:404.37
![(R)-3-(4-(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F54%2Fthumb-webp%2FOR1048014.webp&w=3840&q=75)
![(R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F54%2Fthumb-webp%2FOR302722.webp&w=3840&q=75)
![1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βS)-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA000BIK.webp&w=3840&q=75)
